First application based on CARE1™ has been submitted for FDA review
Aidoc, the global leader in clinical AI, has developed CARE1™ (Clinical AI Reasoning Engine, Version 1), a groundbreaking clinical-grade foundation model for CT imaging, the first step in a multi-year investment in Aidoc’s Clinical AI Reasoning Engine (CARE™) framework. Trained on millions of exams and leveraging advanced multimodal capabilities, the CARE™ framework was developed to establish a new benchmark for precision and speed in developing clinical AI solutions. This innovation is designed to empower clinicians with unparalleled diagnostic accuracy and efficiency, unlocking AI’s full potential to tackle critical healthcare challenges by minimizing diagnostic delays, optimizing workflows and improving patient outcomes. CARE1™ is the culmination of relentless innovation, a bold vision and a significant investment of resources dedicated to this mission.
“Eighteen months ago, we embarked on an ambitious journey to redefine how clinical AI is developed and, in turn, how it serves healthcare,” said Michael Braginsky, CTO of Aidoc. “By unlocking new possibilities for AI, we aim to support clinicians in tackling complex challenges and help them set a new standard for patient care that the prior AI technologies couldn’t achieve. The CARE™ framework will gradually serve as the backbone of Aidoc’s AI solutions, enabling the development of versatile, high-performance AI capable of detecting a broad spectrum of critical conditions in real-time.”
Potential For Unmatched Accuracy Through Expertise, Scale and Innovation
What sets the CARE™ framework apart from other foundation models is its potential for unprecedented accuracy, with internal validations showing it may surpass the performance of Aidoc’s existing AI algorithms, which have already delivered proven clinical outcomes at scale. This breakthrough stems from a combination of unique factors:
By combining expertise, scale and innovation, CARE1™ is designed to redefine what’s possible in clinical AI and is well positioned to set a new benchmark for accuracy, versatility and reliability in healthcare diagnostics.
[FIG. 1] Preliminary internal testing results that demonstrate the performance and consistency of Aidoc’s CARE1™ foundational model across a variety of pathologies. CAUTION: Investigational device. Limited by United States law to investigational use.
FDA Submission: A First Step Toward Transformative AI
As part of Aidoc’s commitment to robust and regulated AI, the company has already submitted its first real-world derivative of the CARE1™ Foundation Model for FDA 510(k) review. This initial application leveraged CARE1™ in Aidoc’s retrained rib fractures triage module with the addition of a pre-training layer. This submission reflects Aidoc’s approach to safely and rigorously transitioning to foundation model-based AI solutions in real-world clinical settings.
“We decided to start this shift by transforming the rib fractures triage module to be CARE1™-enabled, allowing us to begin learning how to measure, validate and ultimately bring foundation model-enabled algorithms to production in clinical settings,” added Braginsky. “This marks a pivotal shift in AI development at Aidoc. We’ve fully committed to foundation model technology because it’s clear this approach surpasses anything we’ve seen before. At the same time, we are steadfast in ensuring this transition is done with precision, focusing on safety, rigorous validation and a comprehensive understanding of this groundbreaking model’s behavior to ensure it delivers meaningful clinical impact.”
Shaping the Future of AI-Driven Healthcare
This breakthrough marks a transformative moment for Aidoc and the future of AI in medicine:
“The future of clinical AI is being reshaped by foundation models, which are set to revolutionize diagnostic workflows in healthcare. We’re encouraged to see the development of these transformative technologies by various leading players, as it underscores their immense potential,” said Elad Walach, CEO of Aidoc. “Ultimately, the true test of success lies in achieving the required accuracy for production-grade solutions. As we’ve all learned over the past decade of advancing clinical AI, the greatest challenge is delivering meaningful outcomes in real-world clinical settings. With CARE1™, Aidoc is just beginning to explore the immense possibilities that foundation models can unlock. Our mission has always been to empower providers to transform the core of diagnostic work, and CARE1™ is only the tip of the iceberg in an exciting journey toward delivering even greater value across the healthcare ecosystem.”
Aidoc experts, customers and industry leaders share the latest in AI benefits and adoption.
Explore how clinical AI can transform your health system with insights rooted in real-world experiences.
Learn how to go beyond the algorithm to develop a scalable AI strategy and implementation plan.
Explore how Aidoc can help increase hospital efficiency, improve outcomes and demonstrate ROI.
